New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。